We Care Life Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-07-2024
- Paid Up Capital ₹ 0.10 M
as on 03-07-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 118.48%
(FY 2021)
- Profit 367.80%
(FY 2021)
- Ebitda 563.43%
(FY 2021)
- Net Worth 5.72%
(FY 2021)
- Total Assets 145.84%
(FY 2021)
About We Care Life Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Biswajit Das and Nitul Kalita serve as directors at the Company.
- CIN/LLPIN
U85300AS2019PTC019567
- Company No.
019567
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Guwahati, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does We Care Life Pharma Private Limited offer?
We Care Life Pharma Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements, Common Disease Medicines, Allopathic Cough Syrup, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Fertilizers and Soil Additives, Fertilizer, Digestive System Drugs & Medicines, Anti Ulcer Drugs.
Who are the key members and board of directors at We Care Life Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Biswajit Das  | Director | 04-Oct-2019 | Current |
| Nitul Kalita | Director | 04-Oct-2019 | Current |
Financial Performance of We Care Life Pharma.
We Care Life Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 118.48% increase. The company also saw a substantial improvement in profitability, with a 367.8% increase in profit. The company's net worth moved up by a moderate rise of 5.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of We Care Life Pharma?
In 2021, We Care Life Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at We Care Life Pharma?
We Care Life Pharma has a workforce of 4 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of We Care Life Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped We Care Life Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
